Company / strategic investorRegistered location :Frankfurt am Main

UBS Europe SEDeclared Swiss shareholdings

UBS Europe SE: 0 Swiss companies with a declared holding.

Disclosure tracking · company alerts with Pro
Estimated value (CHF)
—
Swiss companies held
0
Largest position
—
12-month trend
Not determinable
0 rate rises · 0 rate falls
Latest filing
…

Declared Swiss portfolio

Latest declared rate per company

No active declared position.

How to read these figures?

Rates come from the 198 official filings published by SIX Exchange Regulation. A filing is only required when a threshold is crossed (3, 5, 10, 15, 20, 25, 33⅓, 50, 66⅔%): the actual position may have changed since.

Estimated value = shares held per the latest filing × latest CHF closing price. It is an indicative order of magnitude: the position may have changed without a new threshold being crossed, and holdings without a share count or a CHF price are not valued. Each company's mini-chart traces the successive declared rates.

This profile shows only what the declarant published. No external data is added to it.

Group structure

Shareholding disclosures are often filed jointly by several entities of the same group. The registry links them together: "Controls" lists the group entities declared alongside this shareholder, "Controlled by" the head entities. The figure is the number of joint disclosures, followed by the date of the most recent one.

Show group structure1 controlled by

Controlled by

Group entities that file jointly with this shareholder as its head.

This mapping reflects observed disclosures; it does not necessarily indicate permanent legal control.

Disclosure behaviour

Upward and downward threshold crossings show direction, without measuring daily trades below legal thresholds.

90 days · Upward crossings

0

visible history: 0

90 days · Downward crossings

0

visible history: 0

First disclosure: —Last disclosure: —

Latest shareholding disclosures

Show 37 older disclosures
PurchaseShareholdings

R&S Group Holding AG

UBS Europe SE · Single shareholder

6.929%Voting rights acquired19.09.2026
PurchaseShareholdings

DocMorris AG

UBS Europe SE · Single shareholder

21.116%Voting rights acquired18.09.2026
PurchaseShareholdings

DocMorris AG

UBS Europe SE · Single shareholder

16.985%Voting rights acquired07.08.2026
PurchaseShareholdings

DocMorris AG

UBS Europe SE · Single shareholder

16.636%Voting rights acquired05.08.2026
PurchaseShareholdings

DocMorris AG

UBS Europe SE · Single shareholder

18.281%Voting rights acquired30.07.2026
PurchaseShareholdings

SIG Group Ltd

UBS Europe SE · Single shareholder

8.007%Voting rights acquired05.06.2026
PurchaseShareholdings

DocMorris AG

UBS Europe SE · Single shareholder

18.026%Voting rights acquired21.05.2026
SaleShareholdings

UBS Group AG

UBS Europe SE · Single shareholder

21.3%Voting rights sold10.01.2026
PurchaseShareholdings

DocMorris AG

UBS Europe SE · Single shareholder

18.244%Voting rights acquired26.11.2025
PurchaseShareholdings

DocMorris AG

UBS Europe SE · Single shareholder

16.95%Voting rights acquired26.11.2025
SaleShareholdings

UBS Group AG

UBS Europe SE · Single shareholder

16.884%Voting rights sold05.08.2025
PurchaseShareholdings

DocMorris AG

UBS Europe SE · Single shareholder

12.669%Voting rights acquired05.08.2025
PurchaseShareholdings

DocMorris AG

UBS Europe SE · Single shareholder

10.286%Voting rights acquired19.06.2025
PurchaseShareholdings

DocMorris AG

UBS Europe SE · Single shareholder

10.755%Voting rights acquired06.06.2025
PurchaseShareholdings

DocMorris AG

UBS Europe SE · Single shareholder

28.089%Voting rights acquired23.05.2025
PurchaseShareholdings

DocMorris AG

UBS Europe SE · Single shareholder

27.07%Voting rights acquired12.05.2025
PurchaseShareholdings

DocMorris AG

UBS Europe SE · Single shareholder

27.238%Voting rights acquired07.05.2025
Below thresholdShareholdings

Idorsia Ltd

UBS Europe SE · Single shareholder

3%Below threshold21.03.2025
PurchaseShareholdings

Idorsia Ltd

UBS Europe SE · Single shareholder

6.232%Voting rights acquired20.03.2025
Below thresholdShareholdings

Idorsia Ltd

UBS Europe SE · Single shareholder

3%Below threshold14.03.2025
PurchaseShareholdings

Idorsia Ltd

UBS Europe SE · Single shareholder

6.721%Voting rights acquired13.03.2025
PurchaseShareholdings

Idorsia Ltd

UBS Europe SE · Single shareholder

6.199%Voting rights acquired12.03.2025
PurchaseShareholdings

Idorsia Ltd

UBS Europe SE · Single shareholder

9.498%Voting rights acquired18.02.2025
SaleShareholdings

UBS Group AG

UBS Europe SE · Single shareholder

16.869%Voting rights sold13.02.2025
PurchaseShareholdings

Idorsia Ltd

UBS Europe SE · Single shareholder

12.436%Voting rights acquired11.02.2025
PurchaseShareholdings

DocMorris AG

UBS Europe SE · Single shareholder

27.142%Voting rights acquired04.01.2025
PurchaseShareholdings

DocMorris AG

UBS Europe SE · Single shareholder

26.914%Voting rights acquired14.11.2024
PurchaseShareholdings

DocMorris AG

UBS Europe SE · Single shareholder

27.92%Voting rights acquired05.11.2024
PurchaseShareholdings

DocMorris AG

UBS Europe SE · Single shareholder

28.043%Voting rights acquired01.11.2024
PurchaseShareholdings

DocMorris AG

UBS Europe SE · Single shareholder

28.115%Voting rights acquired29.10.2024
PurchaseShareholdings

Idorsia Ltd

UBS Europe SE · Single shareholder

11.156%Voting rights acquired17.10.2024
PurchaseShareholdings

Idorsia Ltd

UBS Europe SE · Single shareholder

11.398%Voting rights acquired16.10.2024
PurchaseShareholdings

DocMorris AG

UBS Europe SE · Single shareholder

27.859%Voting rights acquired16.10.2024
PurchaseShareholdings

Idorsia Ltd

UBS Europe SE · Single shareholder

9.504%Voting rights acquired15.10.2024
PurchaseShareholdings

DocMorris AG

UBS Europe SE · Single shareholder

28.566%Voting rights acquired03.10.2024
PurchaseShareholdings

Idorsia Ltd

UBS Europe SE · Single shareholder

13.011%Voting rights acquired01.10.2024
PurchaseShareholdings

DocMorris AG

UBS Europe SE · Single shareholder

25.402%Voting rights acquired15.05.2024

insider24.ch

Follow UBS Europe SE’s disclosures

Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

Common questions

Which Swiss companies are in UBS Europe SE’s disclosed portfolio?

No active holding identified in available disclosures.

What is UBS Europe SE’s latest disclosure?

The latest available disclosure was published on 15.10.2026 and concerns DocMorris AG. Threshold disclosures do not describe every purchase or sale.

Explore further

Recent insider purchases

What are insiders doing at companies disclosed by this shareholder?

All purchases this week

Insider barometer

Compare insider purchases and sales across the Swiss stock exchange over 30 days.

View the Swiss barometer

These signals are not investment advice.